2 FTSE 100 value shares I’d buy, and 1 I’d avoid!

These FTSE 100 shares offer eye-popping value for money. But one of them is still too risky at today’s prices, according to our investment writer.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

pensive bearded business man sitting on chair looking out of the window

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m building a list of the best FTSE 100 value shares to buy for my portfolio. I’m looking for companies that trade on low price-to-earnings (P/E) ratios and carry dividends above the 3.7% average.

Here are three that have caught my eye recently. Which stocks should I buy and, which ones should I avoid like the plague?

The following earnings multiples and dividend yields are based on broker projections for the current financial year.

DS Smith

Dividend yield: 8.7 times

P/E ratio: 6%

A massive cardboard shortage is sending earnings at DS Smith (LSE:SMDS) through the roof. Sales and profits at the boxmaker jumped 11% and 75% in the 12 months to April, driven by sizeable price hikes across its packaging product portfolio.

There’s good reason to expect the bottom line to keep shooting higher too. It has the scale and the expertise to exploit rapid growth in the global e-commerce and fast-moving consumer goods (FCMG) sectors. The company counts Amazon and Tesco among its large number of huge and loyal clients.

While acquisitions can be dangerous for a business, DS Smith has a long history of success on this front. A strong balance sheet means it has the firepower to continue making earnings-boosting M&A moves, too.

Tesco

Dividend yield: 11.6 times

P/E ratio: 4.3%

Several shares in my portfolio (including DS Smith) give me exposure to the growing e-commerce sector. As the UK’s biggest online grocery operator Tesco (LSE:TSCO) is another stock I’m looking at today.

Internet-generated supermarket sales have lagged the growth seen across the broader retail arena in recent years. But this provides room for spectacular growth as consumer habits change. Consultancy Strategy& predicts that e-grocery could make up 26% of all food shopping by 2030. That’s up from 11% today.

But despite this bright outlook I’m not tempted to buy Tesco shares today. I don’t like the fierce price wars it’s locked into, led by the value chains Aldi and Lidl as they expand their store estates. Rising online competition is another major worry for me.

Profit margins are wafer thin at supermarkets. Tesco’s adjusted operating margin fell to just 3.8% last year. As discounting heats up and costs rise this gives little scope for profits growth.

GSK

Dividend yield: 9.3 times

P/E ratio: 4.2%

I think buying GSK (LSE:GSK) shares is a much better way to use my hard-earned cash. I expect demand for its drugs to march higher amid rapid population growth and soaring healthcare spending in emerging markets.

The FTSE firm is focused on fast-growing therapy areas to drive profits as well, a strategy that is paying off. Sales of its vaccines for example rose 15% (excluding Covid-19 products) in quarter two, driven by strong demand for its Shingrix shingles treatment.

GSK needs to work extremely hard to improve its underwhelming product pipeline. But the company’s excellent R&D track record leads me to think it has what it takes to develop the next generation of blockbuster drugs.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Royston Wild has positions in DS Smith. The Motley Fool UK has recommended Amazon.com, DS Smith, GSK, and Tesco Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 FTSE 100 stocks hedge funds have been buying

A number of investors have been seeing opportunities in FTSE 100 shares recently. And Stephen Wright thinks two in particular…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Would it be pure madness to pile into the S&P 500?

The S&P 500 is currently in the midst of a skyrocketing bull market, but valuations are stretched. Is there danger…

Read more »

Investing Articles

If I’d put £20k into the FTSE 250 1 year ago, here’s what I’d have today!

The FTSE 250 has outperformed the bigger FTSE 100 over the last year. Roland Head highlights a mid-cap share to…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Growth Shares

The Scottish Mortgage share price is smashing the FTSE 100 again

Year to date, the Scottish Mortgage share price has risen far more than the Footsie has. Edward Sheldon expects this…

Read more »

Investing Articles

As H1 results lift the Land Securities share price, should I buy?

An improving full-year outlook could give the Land Securities share price a boost. But economic pressures on REITs are still…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

How much are Rolls-Royce shares really worth as we approach 2025?

After starting the year at 300p, Rolls-Royce shares have climbed to 540p. But are they really worth that much? Edward…

Read more »

Investing Articles

Despite rocketing 33% this hidden FTSE 100 gem is still dirt cheap with a P/E under 5!

Harvey Jones has been tracking this under -the-radar FTSE 100 growth stock for some time. He thinks it looks a…

Read more »

Dividend Shares

How I could earn a juicy second income starting with just £250

Jon Smith explains how investing a regular amount each month in dividend stocks with above average yields can build a…

Read more »